1. Medtech Insight

ResMed Ready To Supply The Digital Answers To Health Care’s Demand Challenges

Repiratory and sleep group ResMed says COVID-19 has accelerated the transformation of care delivery

 
• By Ashley Yeo

ResMed’s respiratory device portfolio has put the company front and center of the global medtech industry’s efforts to bring COVID-19 under control. UK and Ireland country manager Antoine Valterio tells Medtech Insight how the company rose to the challenge, and how providers are now seeing digital technologies in a new light.

CPAP therapy

Now that peak COVID-19 infection rates have been reached and passed in most of the countries worst affected by the coronavirus, governments and health care systems are turning attentions to managing a sustainable recovery. Returning secondary care to its pre-crisis activity levels and broad mix of services has become a new priority for all health care systems.

But among the lessons for providers learned during the pandemic, a major one is that digital health care must be central in future challenges of these proportions – and increasingly...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.